Veronique Lecault, Chief Operating Officer at AbCellera Biologics Inc. (ABCL), bought 23,000 shares at $20.00 ($460K) on 2020-12-15, disclosed to the SEC on 2020-12-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.00 | 6,000 | $120K | 26.1% |
| 2 | $20.00 | 17,000 | $340K | 73.9% |
| Total | $20.00 avg | 23,000 | $460K | 100% |
| Filing → |
| ABCL | BUY | 2022-03-01 | $4.0M | — | Filing → |
| ABCL | SELL | 2021-06-10 | $25.5M | — | Filing → |